Cabazitaxel

Chemical formula: C₄₅H₅₇NO₁₄  Molecular mass: 835.932 g/mol  PubChem compound: 9854073

Therapeutic indications

Cabazitaxel is indicated for:

Prostate cancer

Population group: men, only adults (18 years old or older)

Cabazitaxel in combination with prednisone or prednisolone is indicated for the treatment of adult patients with metastatic castration resistant prostate cancer previously treated with a docetaxel-containing regimen.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Cabazitaxel is contraindicated in the following cases:

Yellow fever vaccine

Yellow fever vaccines

Severe hepatic impairment (total bilirubin >3 x ULN)

Hepatic failure stage IV

Neutropenia

Neutropenia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2020: CABAZITAXEL ACCORD Concentrate for solution for infusion
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈